Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/30/2007 | CA2560161A1 Production of recombinant human collagen |
03/29/2007 | WO2007035930A2 Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
03/29/2007 | WO2007034809A1 Host cell for producing recombinant protein |
03/29/2007 | WO2007034782A1 Recombinant vector capable of increasing secretion of koji mold protease |
03/29/2007 | WO2007034497A2 Secure data transmission |
03/29/2007 | WO2007012614A3 Novel anti-igf-ir antibodies and uses thereof |
03/29/2007 | WO2007009946A3 Process for the manufacture of eptifibatide |
03/29/2007 | WO2006138225A3 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
03/29/2007 | WO2006128084A3 Trps1-mediated modulation of hair growth |
03/29/2007 | WO2006121810A3 Trimeric ox40-immunoglobulin fusion protein and methods of use |
03/29/2007 | WO2006121664A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
03/29/2007 | WO2005074524A3 Modified human interferon polypeptides and their uses |
03/29/2007 | WO2005053811A3 Biomolecule partition motifs and uses thereof |
03/29/2007 | WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain |
03/29/2007 | WO2004081197A3 Immune response associated proteins |
03/29/2007 | US20070074305 nucleic acid molecule comprising a first nucleic acid segment encoding a polypeptide, and a second nucleic acid segment for suppression of a polypeptide involved in altering oleic acid content in a plant cell |
03/29/2007 | US20070074296 RTD receptor |
03/29/2007 | US20070074295 Schizophrenia related gene |
03/29/2007 | US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4 |
03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
03/29/2007 | US20070073043 Process for producing humanized chimera antibody |
03/29/2007 | US20070073041 Human tumor necrosis factor receptor polypeptides |
03/29/2007 | US20070072797 Epitopes |
03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
03/29/2007 | US20070072271 Method for the production of recombinant proteins |
03/29/2007 | US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide |
03/29/2007 | US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same |
03/29/2007 | US20070072268 Sulfotransferase and DNA encoding the enzyme |
03/29/2007 | US20070072267 Transformant having galactose induction system and use thereof |
03/29/2007 | US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof |
03/29/2007 | US20070072265 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides |
03/29/2007 | US20070072264 Recombinant chimeric acetylcholine receptors and their derivatives recognized by cd4 t cells of myasthenic patients for the treatment of myasthenia gravis |
03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog |
03/29/2007 | US20070072262 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2) |
03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
03/29/2007 | US20070072259 Fluorescent protein |
03/29/2007 | US20070072249 Human cytokine and alpha-helix-containing polypeptides |
03/29/2007 | US20070072247 Methods and reagents for the analysis and purification of polysaccharides |
03/29/2007 | US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein |
03/29/2007 | US20070072238 Wnt-frizzled chimera |
03/29/2007 | US20070072231 Tumor suppressor gene |
03/29/2007 | US20070072225 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
03/29/2007 | US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents |
03/29/2007 | US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
03/29/2007 | US20070072202 toll-like receptors; lipoproteins |
03/29/2007 | US20070072200 useful in screening for small molecule inhibitors of X4 vs R5 viruses, for focusing antiviral therapies based on the predominant or exclusive type of HIV-1 virus present (X4 vs R5) and for creating templates for rational vaccine design |
03/29/2007 | US20070072186 Methods and agents for screening for compounds capable of modulating her2 expression |
03/29/2007 | US20070072185 Carbohydrate-binding modules of a new family |
03/29/2007 | US20070072183 Topoisomerase hybrids and methods of use |
03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
03/29/2007 | US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
03/29/2007 | US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy |
03/29/2007 | US20070071755 Novel nucleolar GTPases and method for controlling proliferation of cells |
03/29/2007 | US20070071752 Sphingosine kinase enzyme |
03/29/2007 | US20070071751 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
03/29/2007 | US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect |
03/29/2007 | US20070071744 Agents which bind to epitopes of glycoprotein VI |
03/29/2007 | US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
03/29/2007 | US20070071741 OCL-2A3 compositions and uses thereof |
03/29/2007 | US20070071724 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing Uch-L1 activity and methods for identifying enhancers of Uch-L1 activity |
03/29/2007 | US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha |
03/29/2007 | US20070071714 Stem cell factor |
03/29/2007 | US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer |
03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
03/28/2007 | EP1767645A1 Transglycosylation method and method for producing glycoprotein |
03/28/2007 | EP1767640A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium |
03/28/2007 | EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant |
03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
03/28/2007 | EP1767635A1 Fluorescent protein |
03/28/2007 | EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins |
03/28/2007 | EP1767628A1 Process for producing dipeptides or dipeptide derivatives |
03/28/2007 | EP1767627A1 Anti-perp antibody |
03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
03/28/2007 | EP1767103A2 Porphyrin containing lactic acid bacterial cells and use thereof |
03/28/2007 | EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation |
03/28/2007 | EP1766098A2 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
03/28/2007 | EP1766040A2 Methods for transforming and expression screening of filamentous fungal cells with a dna library |
03/28/2007 | EP1766039A2 Methods of making nanotechnological and macromolecular biomimetic structures |
03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
03/28/2007 | EP1766000A1 Improved methods of producing heterologous proteases |
03/28/2007 | EP1765996A2 Mammalian endonucleases and methods of use |
03/28/2007 | EP1765994A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof |
03/28/2007 | EP1765993A2 Truncated st6galnaci polypeptides and nucleic acids |
03/28/2007 | EP1765854A1 An expression system comprising operably linked rgg gene and gtfg promoter |
03/28/2007 | EP1765418A2 Method for enhancing production of isoprenoid compounds |
03/28/2007 | EP1765386A2 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
03/28/2007 | EP1765316A2 Methods and compositions for modulating bax-ku70-mediated apoptosis |
03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
03/28/2007 | EP1309604B1 Phage-dependent superproduction of biologically active protein and peptides |
03/28/2007 | EP0815246B1 Methods and compositions for secretion of heterologous polypeptides |
03/28/2007 | CN1938425A Process for producing dipeptides |
03/28/2007 | CN1936014A H5 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein |
03/28/2007 | CN1936009A Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation |
03/28/2007 | CN1935996A H9 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein |
03/28/2007 | CN1935995A H7 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein |